Delivery Order SPE2DB22D2009-SPE2DB24FL6BE
Award Date 10/21/23
Potential Completion Date 10/23/23
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,042.14 firm fixed-price delivery order is for the supply of Exforge 5-160 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of December 8, 2022 and was awarded on December 7, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The $2,797.79 firm fixed-price contract has a period of performance through February 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award from the Defense Logistics Agency (DLA) is a delivery order under an Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corporation's Corporate Office division. The $3,221.03 firm fixed price contract is for the delivery of Exforge 5-160 mg tablets, a prescription medication. The award is not set aside and is part of Amerisourcebergen's broader IDC with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,262.36, is a Delivery Order contract for the supply of Exforge HCT 10-160-12.5 mg tablets. The contract has an ultimate completion date of November 20, 2024 and is a Firm Fixed Price (FFP) arrangement. This award does not have a set-aside designation, indicating open competition....
- This federal contract award is for the delivery of Exforge 5-160 mg tablet medication, with a ceiling value of $2,272.81. The contract was awarded by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,862.00, is to provide pharmaceutical products including the medication Exforge HCT 5-160-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,242.94, is for the delivery of Exforge 5-160 mg tablets. It is a delivery order contract with a firm fixed price pricing type and has a completion date of May 2, 2023. The award does not have a set-aside designation, indicating it was awarded through full and open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Exforge 5-160 mg tablets. The contract, valued at $1,323.76, has a firm fixed price pricing type and an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999...
- This federal contract award, identified as SPE2DB22D1106|SPE2DB25FEKU9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,309.47 firm fixed-price delivery order is for the supply of Exforge 10-320 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of April 29, 2025 and is not set-aside. Amerisourcebergen Drug Corp holds a substantial...
- This federal contract award is for the delivery of Exforge 5-160 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The $1,812.18 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 7, 2023, with a completion date of June 8, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...